COVID-Gate: The Corruption of Clinical Trials
"Truly striking." "Tremendous." "Extraordinary." "Miraculous." "A great day for science and humanity." Those are just a few of the hyperbolic responses from government health officials and Big Pharma cheerleaders to preliminary COVID vaccine trial data released by Pfizer and Moderna this past week.
If it all sounds too good to be true, then congratulations: Your B.S. detector is fully charged and operational.
Mask flip-flop-flipper Dr. Anthony Fauci proclaimed on Monday that COVID-19 vaccines are "the light at the end of the tunnel." Pffft. He has been promising a "light at the end of the tunnel" since April when Americans were told to endure lockdowns for just "15 days to stop the spread." Now, seven months later, Fauci tells us that we won't return to "relative normalcy" until April 2021 -- only after face diaper-wrapped citizens "do what you're told" and "we get most of the country vaccinated."
Yikes. Ticketmaster, Tokyo Olympics organizers and the travel industry are now exploring vaccine status verification systems based on the public health industrial complex's high, heavenly and hasty promises. Based on the press release write-ups of the uncompleted clinical trials, which have yet to be finalized or subjected to scientific peer review, Fauci assures us that "all the boxes have been checked" on vaccine safety and efficacy.
But what about these boxes:
--Big Pharma cannot tell you how long the alleged protection of COVID-19 vaccines will last.
--Big Pharma has zero data on young children's response to their warp speed-produced jabs, even as schools across the globe prepare to mandate it as a condition of access to education.
--Big Pharma can't tell you about the synergistic effects of the COVID-19 vaccine with other vaccines.
--Nor can Big Pharma tell you about the long-term side effects of its "miraculous" shots. (And don't forget the astonishing fact that vaccine makers are immune from lawsuits by vaccine-injured Americans.)
Here's what we do know: The Pfizer clinical trial enrolled 43,538 participants, of whom 94 (about two-tenths of 1%) were identified as having COVID-19. The Moderna clinical trial included more than 30,000 participants, of whom 95 (about three-tenths of 1%) were categorized as having COVID-19. In other words: The vaccine is being tested on people who are at incredibly low risk of COVID-19 -- not only the vaccinated enrollees but also the unvaccinated.